SFSIG
GSK icon

San Francisco Sentry Investment Group’s GSK GSK Stock Holding History

San Francisco Sentry Investment Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$142K Sell
2,852
-56
-2% -$2.69K 0.07% 238
2021
Q1 		$130K Buy
2,908
+876
+43% +$39.8K 0.06% 270
2020
Q4 		$93K Buy
2,032
+1,512
+291% +$69.5K 0.04% 283
2020
Q3 		$24K Sell
520
-600
-54% -$30.1K 0.01% 413
2020
Q2 		$57K Hold
1,120
– – 0.03% 313
2020
Q1 		$53K Buy
1,120
+600
+115% +$32K 0.03% 278
2019
Q4 		$31K Hold
520
– – 0.01% 431
2019
Q3 		$28K Hold
520
– – 0.01% 445
2019
Q2 		$26K Hold
520
– – 0.01% 450
2019
Q1 		$27K Hold
520
– – 0.01% 462
2018
Q4 		$25K Sell
520
-4,231
-89% -$208K 0.01% 446
2018
Q3 		$238K Sell
4,751
-8
-0.2% -$406 0.09% 184
2018
Q2 		$240K Buy
4,759
+348
+8% +$17.5K 0.1% 177
2018
Q1 		$216K Buy
4,411
+20
+0.5% +$931 0.06% 260
2017
Q4 		$194K Sell
4,391
-2,608
-37% -$120K 0.06% 266
2017
Q3 		$356K Buy
6,999
+3,671
+110% +$186K 0.12% 171
2017
Q2 		$179K Sell
3,328
-1,024
-24% -$54.6K 0.06% 239
2017
Q1 		$229K Buy
4,352
+4
+0.1% +$203 0.13% 170
2016
Q4 		$210K Buy
+4,348
New +$215K 0.12% 171
2014
Q4 		– Sell
-784
Closed -$45K – 256
2014
Q3 		$45K Hold
784
– – 0.02% 309
2014
Q2 		$52K Sell
784
-12
-2% -$812 0.02% 313
2014
Q1 		$53K Buy
796
+32
+4% +$2.16K 0.02% 353
2013
Q4 		$51K Buy
764
+92
+14% +$5.96K 0.02% 323
2013
Q3 		$42K Buy
672
+120
+22% +$7.72K 0.02% 328
2013
Q2 		$34K Buy
+552
New +$35K 0.01% 347

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

San Francisco Sentry Investment Group's GSK Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its GSK (GSK) stake by 1.9% in Q2 2021, selling an estimated $2.69K and leaving 2,852 shares worth $142K. The position accounts for 0.07% of the portfolio, ranked #238.

San Francisco Sentry Investment Group first reported a position in GSK in Q2 2013 and has held it in 25 quarters since. The position peaked at $356K in Q3 2017. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • San Francisco Sentry Investment Group held 2,852 shares of GSK worth $142K as of Q2 2021.
  • San Francisco Sentry Investment Group sold 56 GSK shares in Q2 2021, an estimated $2.69K.
  • GSK made up 0.07% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #238 holding.
  • San Francisco Sentry Investment Group first reported a position in GSK in Q2 2013 and has held it in 25 quarters since.
  • San Francisco Sentry Investment Group's GSK position peaked at $356K in Q3 2017.
  • 798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.